Citigroup maintains Buy on RBL Bank with a ₹390 target despite RoA hit from NIM compression and elevated credit costs.
Strong 11% loan growth, NIM recovery, easing JLG stress, and ENBD infusion support positive long-term outlook.
Livesquawk •
CLSA maintains 'Hold' on RBL Bank with TP ₹320 after weak Q4 results.
Q4 saw ~20% PBT miss due to soft PPOP, 2.5% credit costs, and tepid NII growth.